Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2008
by National Cancer Institute (NCI).
Recruitment status was Active, not recruiting
Study NCT00002869 Information provided by National Cancer Institute (NCI)
First Received on November 1, 1999. Last Updated on June 4, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Leukemia
Additional conditions recognized in this trial
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Leukemia, Myeloid
Leukemia, Myeloid, Chronic-Phase
More general conditions related to this trial
Bone Marrow Diseases
Hematologic Diseases
Myeloproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
recombinant interferon alfa
cytarabine
hydroxyurea
Additional drug interventions recognized in this trial
Interferon Alfa-2a
Interferon-alpha
Interferons
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Anti-Infective Agents
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antisickling Agents
Antiviral Agents
Enzyme Inhibitors
Growth Inhibitors
Growth Substances
Hematologic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Medical Research Council
Back to top of Main Content
